FRUQUINTINIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 16 adverse event reports in the FDA FAERS database where FRUQUINTINIB was used for Neoplasm malignant.
Most Reported Side Effects for FRUQUINTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 647 | 25.2% | 647 | 79 |
| Fatigue | 366 | 14.3% | 104 | 96 |
| Colon cancer | 277 | 10.8% | 53 | 37 |
| Blood pressure increased | 223 | 8.7% | 49 | 74 |
| Diarrhoea | 213 | 8.3% | 52 | 80 |
| Colorectal cancer metastatic | 212 | 8.3% | 53 | 20 |
| Decreased appetite | 184 | 7.2% | 55 | 77 |
| Asthenia | 178 | 6.9% | 51 | 66 |
| Dysphonia | 176 | 6.9% | 45 | 53 |
| Off label use | 133 | 5.2% | 32 | 67 |
| Nausea | 132 | 5.2% | 46 | 49 |
| Myelosuppression | 122 | 4.8% | 1 | 74 |
| Pain | 117 | 4.6% | 31 | 48 |
| Hypertension | 115 | 4.5% | 10 | 32 |
| Product dose omission issue | 94 | 3.7% | 23 | 33 |
Other Indications for FRUQUINTINIB
Colon cancer (1,057)
Rectal cancer (367)
Colorectal cancer metastatic (357)
Product used for unknown indication (354)
Rectosigmoid cancer (71)
Colorectal cancer (53)
Metastases to liver (50)
Gastric cancer (49)
Adenocarcinoma of colon (39)
Colon cancer metastatic (39)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)